Literature DB >> 21748389

Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma.

Keitaro Sofue1, Masakatsu Tsurusaki, Hiroyuki Tokue, Yasuaki Arai, Kazuro Sugimura.   

Abstract

OBJECTIVE: To compare quantitatively and qualitatively hepatocyte-phase images obtained 10 and 20 min (Images-10, and Images-20) after injection of gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA) to detect liver metastases from colorectal carcinoma on 3.0 T MR imaging.
METHODS: A total of 48 patients (26 men, 22 women; mean age, 64 years) with 88 histopathologically confirmed liver metastases underwent Gd-EOB-DTPA-enhanced MR imaging. Tumour-to-liver contrast-to-noise ratio (CNR), signal intensity gain (SIG) of liver parenchyma and overall image quality were analysed. Two radiologists independently reviewed two sets of MR images: set 1, unenhanced (T1- and T2-weighted), dynamic images and Images-10; set 2, unenhanced, dynamic and Images-20. Sensitivity and positive predictive value (PPV) to detect liver metastases, and diagnostic performance using the alternative free-response receiver operating characteristics (AFROC) method were calculated.
RESULTS: The mean tumour-to-liver CNR, SIG of liver parenchyma and overall image quality on Images-20 were significantly higher than those on Images-10. The overall image quality of "fair to excellent" was achieved on both images in 93.8% of the patients. Sensitivity, PPV and area under the AFROC curve on set 1 were similar to set 2, including lesions <1 cm.
CONCLUSION: In detecting liver metastases from colorectal carcinoma, Images-10 could replace Images-20 in 3.0 T MR imaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748389     DOI: 10.1007/s00330-011-2197-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

Review 1.  Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?

Authors:  Shahid M Hussain; Piotr A Wielopolski; Diego R Martin
Journal:  Top Magn Reson Imaging       Date:  2005-07

2.  Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease.

Authors:  Masakatsu Tsurusaki; Richard C Semelka; Mauricio Zapparoli; Jorge Elias; Ersan Altun; Ertan Pamuklar; Kazuro Sugimura
Journal:  Eur J Radiol       Date:  2008-09-13       Impact factor: 3.528

3.  Abdominal MR imaging at 3.0 T.

Authors:  Fatih M Akisik; Kumaresan Sandrasegaran; Alex M Aisen; Chen Lin; Chandana Lall
Journal:  Radiographics       Date:  2007 Sep-Oct       Impact factor: 5.333

Review 4.  Abdominal MRI at 3.0 T: the basics revisited.

Authors:  Elmar M Merkle; Brian M Dale
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

5.  Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations.

Authors:  R C Semelka; S M Hussain; H B Marcos; J T Woosley
Journal:  Radiology       Date:  2000-04       Impact factor: 11.105

6.  Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings.

Authors:  Y Yamashita; I Ogata; J Urata; M Takahashi
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

7.  Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.

Authors:  W Stern; F Schick; A F Kopp; P Reimer; K Shamsi; C D Claussen; M Laniado
Journal:  Acta Radiol       Date:  2000-05       Impact factor: 1.990

8.  Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Authors:  Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2008-07       Impact factor: 6.016

9.  Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time?

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Licht Tominaga; Hironobu Sou; Katsuhiro Sano; Shintaro Ichikawa; Tsutomu Araki
Journal:  Eur Radiol       Date:  2009-05-27       Impact factor: 5.315

Review 10.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

View more
  18 in total

1.  Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.

Authors:  Zhi-Peng Zhou; Li-Ling Long; Li-Juan Huang; Teng-Fei Yang; Zhong-Kui Huang
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

2.  Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Takamichi Murakami; Shunsuke Onoe; Hiroyuki Tokue; Kentaro Shibamoto; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

3.  Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.

Authors:  Cherry Kim; So Yeon Kim; Min-Ju Kim; Yong Sik Yoon; Chan Wook Kim; Jae Hoon Lee; Kyu-Pyo Kim; Seung Soo Lee; Seong Ho Park; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2018-04-24       Impact factor: 5.315

4.  Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Authors:  Mustafa R Bashir; Steven R Breault; Ryan Braun; Richard K Do; Rendon C Nelson; Scott B Reeder
Journal:  Acad Radiol       Date:  2014-04-06       Impact factor: 3.173

5.  Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.

Authors:  Ling Zhang; Xian Yu; Lei Huo; Lun Lu; Xinpeng Pan; Ningyang Jia; Xinxiang Fan; Giovanni Morana; Luigi Grazioli; Guenther Schneider
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

6.  Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Authors:  Ying Ding; Sheng-Xiang Rao; Tao Meng; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2014-01-26       Impact factor: 5.315

7.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.

Authors:  Valérie Vilgrain; Maxime Esvan; Maxime Ronot; Aurore Caumont-Prim; Christophe Aubé; Gilles Chatellier
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

8.  Convolutional neural network-automated hepatobiliary phase adequacy evaluation may optimize examination time.

Authors:  Guilherme Moura Cunha; Kyle A Hasenstab; Atsushi Higaki; Kang Wang; Timo Delgado; Ryan L Brunsing; Alexandra Schlein; Armin Schwartzman; Albert Hsiao; Claude B Sirlin; Katie J Fowler
Journal:  Eur J Radiol       Date:  2020-01-14       Impact factor: 3.528

9.  Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases.

Authors:  Lihua Chen; Jiuquan Zhang; Lin Zhang; Jing Bao; Chen Liu; Yunbao Xia; Xuequan Huang; Jian Wang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Prediction of Sufficient Liver Enhancement on the Gadoxetate Disodium-enhanced Hepatobiliary Phase Imaging Using Transitional Phase Images and Albumin-bilirubin Grade.

Authors:  Yasuo Takatsu; Masafumi Nakamura; Satoshi Kobayashi; Tosiaki Miyati
Journal:  Magn Reson Med Sci       Date:  2020-05-27       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.